Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Zhiwei Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5121-0687; OpenAlex author ID A5088789363. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers

Papers 8

  1. LINC00431 modulates KRAS and p53 stability to drive pancreatic cancer progression under hypoxia Co-author DOI 10.1016/j.gendis.2025.101696↗
  2. Predictors for low rates of surgical resection in elderly patients with resectable pancreatic ductal adenocarcinoma: a retrospective case-control study. Co-author DOI 10.1097/js9.0000000000001957↗
  3. An in-vivo pilot study of probe-based confocal laser endomicroscopy for detecting of pancreatic ductal adenocarcinoma intraoperatively. Co-author DOI 10.1097/js9.0000000000003754↗
  4. Schwann cells in pancreatic cancer: Unraveling their multifaceted roles in tumorigenesis and neural interactions. Co-author DOI 10.1016/j.canlet.2024.216689↗
  5. RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report. Co-author DOI 10.3389/fonc.2023.1078076↗
  6. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming. Co-author DOI 10.3892/or.2023.8578↗
  7. Cancer‑associated adipocytes exhibit distinct phenotypes and facilitate tumor progression in pancreatic cancer. Co-author DOI 10.3892/or.2019.7365↗
  8. SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition. Co-author DOI 10.1093/abbs/gmy110↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chongyi Jiang · 8 shared papers, 2018–2025 · strength 1.60
  2. Chunjing Li · 4 shared papers, 2024–2025 · strength 0.99
  3. Hong‐Fei Yao · 4 shared papers, 2024–2025 · strength 0.99
  4. Jia-Hao Chen · 1 shared paper, 2025 · strength 0.28
  5. Jianxia Ma · 1 shared paper, 2025 · strength 0.25
  6. Tongyi Zhang · 1 shared paper, 2023 · strength 0.24
  7. Yu-Heng Zhu · 1 shared paper, 2025 · strength 0.24
  8. Mingjian Ma · 1 shared paper, 2023 · strength 0.20
  9. Pengfei Hu · 2 shared papers, 2018–2019 · strength 0.17
  10. Wei Wang · 2 shared papers, 2018–2019 · strength 0.17
  11. Qiangsheng Hu · 1 shared paper, 2018 · strength 0.07
  12. Jiaqi He · 1 shared paper, 2018 · strength 0.07
  13. Xianjun Yu · 1 shared paper, 2018 · strength 0.07
  14. Yi Qin · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.